Genedata Collaborates with Kluyver Centre for Genomics of Industrial Fermentation
News Jun 16, 2006
Genedata has announced its collaboration with the Netherlands’ Kluyver Centre. The Swiss bioinformatics company will support high throughput genomics data analysis and result sharing among the consortium’s 9 interdisciplinary research partners.
The Kluyver Centre brings together fermentation experts from industry and academia to enhance this lucrative industrial sector.
Research focuses on fermentation in yeast, filamentous fungi and lactic acid bacteria and involves sequencing, genome-wide functional studies and strain and process design.
Genedata’s computational solutions will support all aspects of this research program.
Professor De Winde, business director of the Kluyver Centre, explained, "We needed a research informatics partner able to support a complete systems biology workflow."
The consortium will use Genedata Phylosopher® and Expressionist® to support central data storage and provide automated workflows to integrate transcriptomic, proteomic and metabolomic data.
"We will be able to pool genomics expertise across the entire Kluyver Centre network using Genedata’s standardised and integrated informatics resources," explained Professor Pronk, scientific director of the Kluyver Centre.
"We are proud to collaborate with this world class public-private research consortium," said Dr. Othmar Pfannes, CEO of Genedata AG.
Genedata currently supports several research consortia in Europe and has developed computational solutions tailored towards multi-site, multi-year research programs.
Dr. Pfannes added, "Our computational solutions anticipate the evolving needs of research groups that adopt a systems biology approach."
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.